Fulcrum Therapeutics Inc. (FULC)
4.08
0.08 (2.00%)
At close: Jan 22, 2025, 3:59 PM
4.09
0.12%
After-hours Jan 22, 2025, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Revenue | 2.81M | 6.34M | 19.16M | 8.82M | n/a | n/a | n/a |
| Cost of Revenue | n/a | 2.41M | 2.52M | 2.38M | 2.05M | 1.34M | 715.00K |
| Gross Profit | 2.81M | 3.93M | 16.65M | 6.44M | -2.05M | -1.34M | -715.00K |
| Operating Income | -110.66M | -112.56M | -81.05M | -71.61M | -84.22M | -33.50M | -22.99M |
| Interest Income | n/a | n/a | 207.00K | 792.00K | 1.51M | n/a | n/a |
| Pretax Income | -97.33M | -109.87M | -80.85M | -70.82M | -82.68M | -32.59M | -22.96M |
| Net Income | -97.33M | -105.62M | -78.33M | -68.44M | -79.11M | -32.59M | -22.96M |
| Selling & General & Admin | 41.67M | 41.69M | 30.52M | 21.39M | 13.14M | 8.31M | 4.50M |
| Research & Development | 71.80M | 76.78M | 69.70M | 59.04M | 71.07M | 25.18M | 18.49M |
| Other Expenses | n/a | 2.69M | 207.00K | 792.00K | 29.00K | 392.00K | 28.00K |
| Operating Expenses | 113.47M | 118.48M | 100.22M | 80.43M | 84.22M | 33.50M | 22.99M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 113.47M | 118.48M | 100.22M | 80.43M | 84.22M | 33.50M | 22.99M |
| Income Tax | n/a | -4.25M | -2.52M | -2.38M | -3.56M | 910.00K | -1K |
| Shares Outstanding (Basic) | 61.31M | 44.99M | 35.36M | 25.35M | 11.05M | 16.94M | 10.95M |
| Shares Outstanding (Diluted) | 61.31M | 44.99M | 35.36M | 25.35M | 11.05M | 16.94M | 10.95M |
| EPS (Basic) | -1.59 | -2.35 | -2.22 | -2.7 | -7.16 | -1.92 | -2.1 |
| EPS (Diluted) | -1.59 | -2.35 | -2.22 | -2.7 | -7.16 | -1.92 | -2.1 |
| EBITDA | -108.49M | -109.72M | -78.54M | -69.23M | -82.16M | -32.15M | -22.28M |
| Depreciation & Amortization | 2.17M | 2.41M | 2.52M | 2.38M | 2.05M | 1.34M | 715.00K |